ONCOLOGX: what changed
ONCOLOGX
Largest movements
- Tangible fixed assets -€31,594
down €31,594 (-12.5%), from €251,816 to €220,222
- Deferred charges and accrued income +€18,300
new in 2025: €18,300
- Cash +€12,835
up €12,835 (+18.4%), from €69,584 to €82,419
mainly Depreciation (+€31,594) and Net result for the year (+€17,466)
- Current investments +€12,316
up €12,316 (+13.5%), from €91,401 to €103,717
- Receivables within one year +€4,440
up €4,440 (+142%), from €3,137 to €7,577
of which Trade receivables: +€7,089
- Reserves +€17,460
up €17,460 (+4.4%), from €394,150 to €411,610
of which Distributable reserves: +€17,460
- Gross operating margin +€32,439
up €32,439 (+110%), from €29,510 to €61,950
- Depreciation +€10,705
up €10,705 (+51.2%), from €20,889 to €31,594
- Taxes +€6,492
up €6,492 (+241%), from €2,696 to €9,189
- Other operating charges +€1,668
up €1,668 (+78.7%), from €2,119 to €3,786
- Financial income -€1,408
down €1,408 (-66.4%), from €2,119 to €711
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €415,938 | €432,235 | +€16,297 | +3.9% |
| Fixed assets | 21/28 | €251,816 | €220,222 | -€31,594 | -12.5% |
| Tangible fixed assets | 22/27 | €251,816 | €220,222 | -€31,594 | -12.5% |
| Land and buildings | 22 | €194,790 | €182,424 | -€12,366 | -6.3% |
| Plant, machinery and equipment | 23 | €1,672 | €1,323 | -€349 | -20.9% |
| Furniture and vehicles | 24 | €40,601 | €25,515 | -€15,086 | -37.2% |
| Other tangible fixed assets | 26 | €14,752 | €10,960 | -€3,793 | -25.7% |
| Current assets | 29/58 | €164,122 | €212,012 | +€47,891 | +29.2% |
| Amounts receivable within one year | 40/41 | €3,137 | €7,577 | +€4,440 | +142% |
| Trade receivables | 40 | €171 | €7,260 | +€7,089 | +4,134% |
| Other amounts receivable | 41 | €2,966 | €317 | -€2,648 | -89.3% |
| Current investments | 50/53 | €91,401 | €103,717 | +€12,316 | +13.5% |
| Cash at bank and in hand | 54/58 | €69,584 | €82,419 | +€12,835 | +18.4% |
| Deferred charges and accrued income | 490/1 | - | €18,300 | +€18,300 | |
| Total equity and liabilities | 10/49 | €415,938 | €432,235 | +€16,297 | +3.9% |
| Equity | 10/15 | €402,113 | €419,578 | +€17,466 | +4.3% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €394,150 | €411,610 | +€17,460 | +4.4% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €392,290 | €409,750 | +€17,460 | +4.5% |
| Profit (loss) carried forward | 14 | €1,763 | €1,768 | +€6 | +0.3% |
| Amounts payable | 17/49 | €13,825 | €12,656 | -€1,169 | -8.5% |
| Amounts payable within one year | 42/48 | €13,825 | €12,321 | -€1,504 | -10.9% |
| Trade debts | 44 | €1,516 | €765 | -€752 | -49.6% |
| Suppliers | 440/4 | €1,516 | €765 | -€752 | -49.6% |
| Taxes, remuneration and social security | 45 | €4,262 | €4,518 | +€255 | +6.0% |
| Taxes | 450/3 | €4,262 | €4,518 | +€255 | +6.0% |
| Other amounts payable | 47/48 | €8,046 | €7,039 | -€1,007 | -12.5% |
| Accrued charges and deferred income | 492/3 | €0 | €335 | +€335 | |
| Non-recurring operating income | 76A | €4,525 | €0 | -€4,525 | -100% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €20,889 | €31,594 | +€10,705 | +51.2% |
| Other operating charges | 640/8 | €2,119 | €3,786 | +€1,668 | +78.7% |
| Gross operating margin | 9900 | €29,510 | €61,950 | +€32,439 | +110% |
| Operating profit (loss) | 9901 | €6,503 | €26,570 | +€20,067 | +309% |
| Financial income | 75/76B | €2,119 | €711 | -€1,408 | -66.4% |
| Recurring financial income | 75 | €2,119 | €711 | -€1,408 | -66.4% |
| Financial charges | 65/66B | €497 | €626 | +€129 | +26.0% |
| Recurring financial charges | 65 | €497 | €626 | +€129 | +26.0% |
| Profit (loss) for the period before taxes | 9903 | €8,124 | €26,655 | +€18,530 | +228% |
| Income taxes | 67/77 | €2,696 | €9,189 | +€6,492 | +241% |
| Profit (loss) for the period | 9904 | €5,428 | €17,466 | +€12,038 | +222% |
| Profit (loss) for the period to be appropriated | 9905 | €5,428 | €17,466 | +€12,038 | +222% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.